Want to see BVS full AI Analyst Report?
Revenue by Segment
Analyzes revenue from different business segments, highlighting which areas are driving growth and which may need strategic adjustments to improve performance.Pain Treatments remains the largest and primary growth lever—recent quarters show strong spikes including a big late‑2025 jump, but management cautioned Q1 was aided by a one‑time rebate and distributor timing so underlying Pain growth is mid‑single digits. Surgical Solutions is a steadier, durable grower with management expecting H2 acceleration after a planned slow Q1. Restorative Therapies has materially rolled off from its 2021–22 peaks and now contributes far less, prompting reallocations into PNS/PRP/Ultrasonics to drive future upside.
Date | Pain Treatments | Surgical Solutions | Restorative Therapies |
|---|---|---|---|
Jun 30, 2026 | $81.75M | $50.35M | $21.11M |
Mar 31, 2026 | $63.43M | $48.03M | $20.64M |
Dec 31, 2025 | $89.74M | $55.53M | $22.71M |
Sep 30, 2025 | $67.18M | $50.17M | $21.31M |
Jun 30, 2025 | $73.31M | $52.72M | $21.64M |
Mar 31, 2025 | $58.92M | $45.23M | $19.72M |
Dec 31, 2024 | $69.21M | $53.72M | $30.70M |
Sep 30, 2024 | $63.13M | $45.90M | $29.94M |
Jun 30, 2024 | $72.26M | $47.34M | $31.62M |
Mar 31, 2024 | $56.69M | $42.29M | $30.47M |